EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review

Lele Sun, Yuanyuan Yang iD, Wenyi Pan iD, Chenghua Zhang iD, Jiawei Lu, Shaowen Guo, Ying Zhu, Meifeng Zhu iD

Diabetes, Metabolic Syndrome and Obesity · 2026-05 · Volume 19 · 1-18

DOI: 10.2147/dmso.s599060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-05. Verfasst von Lele Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic Kidney Disease (DKD) is one of the common and serious microvascular complications of diabetes, and the pathogenesis is complex and incompletely understood. Recent studies have shown that lactylation, as a novel form of protein post-translational modification, has been increasingly involved in the progression of DKD through the specific binding of lactate molecules to protein amino acid residues, particularly involving important pathological processes such as inflammatory regulation, cell death-related signaling pathways and fibrotic remodeling. This review summarizes current evidence on abnormal lactate metabolism in DKD and the mechanisms by which lactate-driven lactylation regulates signaling pathways associated with kidney injury. It further evaluates the potential of lactate as a clinical biomarker and discusses intervention strategies targeting lactate metabolism as well as enzymes involved in lactylation and delactylation. These findings provide new insights and future research directions for the prevention and treatment of DKD. Plain Language Summary: Diabetic kidney disease is a major cause of chronic kidney failure in people with diabetes, yet current treatments do not fully prevent disease progression. Understanding the biological mechanisms that drive kidney damage remains essential for developing better therapies. This review examines how changes in cellular metabolism contribute to diabetic kidney disease, with a focus on lactate, a key product of glucose metabolism. Beyond its traditional role in energy production, lactate can modify proteins through a process known as lactylation, which influences gene activity and cellular behavior. Recent studies suggest that abnormal lactate metabolism and protein lactylation may promote inflammation, tissue scarring, and cell dysfunction in the diabetic kidney. We summarize current evidence from experimental and clinical studies linking lactate-related pathways to kidney injury and disease progression. We also discuss the limitations of existing research and highlight important gaps that require further investigation. By clarifying how metabolic signals influence kidney pathology, this review provides insight into potential therapeutic targets and supports future research aimed at improving outcomes for people with diabetic kidney disease. Keywords: diabetic kidney disease, lactate, lactate metabolism, glycolysis, post-translational modification, protein lactylation, renal fibrosis

Schlagwörter

Stichwörter der Autor:innen

diabetic kidney diseaseglycolysislactatelactate metabolismpost-translational modificationprotein lactylationrenal fibrosis

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
  • Department of Nephrology, Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine, Changzhou, Jiangsu, People's Republic of China.
  • Department of Nephrology, Changshu Affiliated Hospital of Nanjing University of Chinese Medicine, Changshu, Jiangsu, People's Republic of China.

ORCID-Profile: Yuanyuan Yang, Wenyi Pan, Chenghua Zhang, Meifeng Zhu

Zitieren

APA

Sun, L., Yang, Y., Pan, W., Zhang, C., Lu, J., Guo, S., Zhu, Y., & Zhu, M. (2026). Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-18. https://doi.org/10.2147/dmso.s599060

Vancouver

Sun L, Yang Y, Pan W, Zhang C, Lu J, Guo S, et al. Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-18. doi:10.2147/dmso.s599060

BibTeX
@article{Sun2026,
  author = {Sun, Lele and Yang, Yuanyuan and Pan, Wenyi and Zhang, Chenghua and Lu, Jiawei and Guo, Shaowen and Zhu, Ying and Zhu, Meifeng},
  title = {Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  year = {2026},
  volume = {Volume 19},
  pages = {1--18},
  doi = {10.2147/dmso.s599060}
}
Kostenlos starten →